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Neurotrophins are key players of neural development by controlling cell death programs.
However, the signaling pathways that mediate their selective responses in different
populations of neurons remain unclear. In the mammalian cochlea, sensory neurons
differentiate perinatally into type I and II populations both expressingTrkB andTrkC, which
bind respectively brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3). How
these two neuronal populations respond differentially to these two neurotrophins remains
unknown. Here, we report in rat the segregation of the nuclear factor-κB (NFκB) subunit
p65 speciﬁcally within the type II population postnatally. Using dissociated cultures of
embryonic and postnatal spiral ganglion neurons, we observed a speciﬁc requirement of
NFκB for BDNF- but not NT3-dependent neuronal survival during a particular postnatal
time window that corresponds to a period of neuronal cell death and hair cell innervation
reﬁnement in the developing cochlea. Consistently, postnatal p65 knockout mice showed a
speciﬁc decreased number in type II spiral ganglion neurons.Taken together, these results
identify NFκB as a type II neuron-speciﬁc factor that participates in the selective survival
effects of BDNF and NT3 signaling on developing spiral ganglion neurons.
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INTRODUCTION
In the developing nervous system, the selectivity of the neu-
rotrophins for the survival of particular populations of neurons
during development depends not only on the speciﬁc spa-
tiotemporal pattern of expression of the ligand in the target
tissue but also of its corresponding Trk receptors in the neu-
rons. However, while Trk receptors are structurally similar,
their speciﬁc binding can lead to the activation of differ-
ent signaling pathways with distinct impacts on target inner-
vation and neuronal survival in vivo (Postigo et al., 2002;
Nikoletopoulou et al., 2010). Although signiﬁcant progress has
been made in our understanding of the speciﬁcity of the
downstream effectors different Trk receptors are using, the
molecular basis supporting these differences remains not well
understood.
Spiral ganglion neurons (SGNs) constitute the ﬁrst relay of the
acoustic neuroanatomical ascending pathway between the sen-
sory receptors – the inner and outer hair cells (IHCs/OHCs) of
the organ of Corti – of the mammalian cochlea and the central
nervous system (Nayagam et al., 2011). SGNs are divided in two
types: type I neurons innervating speciﬁcally the IHCs, repre-
sent the principal encoder of the auditory signal and account for
about 90% of the neuronal population while the type II neu-
rons, representing the remaining 10%, contact the OHCs and are
thought to provide an integrated afferent feedback loop and to
amplify both cochlear sensitivity and frequency discrimination
(Geleoc and Holt, 2003). The development of SGNs starts at mid
gestation and is completed during the two ﬁrst postnatal weeks
in rodents. Among neurotrophins, brain-derived neurotrophic
factor (BDNF) and neurotrophin-3 (NT3) through their respec-
tive receptors, TrkB and TrkC, have been shown to play a central
role in regulating the development of SGNs (Fritzsch et al., 2005;
Defourny et al., 2011; Yang et al., 2011). Indeed, they are expressed
and secreted by the developing otic sensory epithelium and act
on neuronal TrkB and TrkC to control their survival and the
growth of their projections towards the hair cells (Farinas et al.,
2001; Defourny et al., 2011). As such, mice with knockouts of
the NT3 or the BDNF genes (or of their speciﬁc receptors) have
shown a marked reduction, of about 80–90% (NT3-null) and 10%
(BDNF-null), in SGN number (Farinas et al., 1994; Ernfors et al.,
1995; Tessarollo et al., 1997; Wiechers et al., 1999). This differen-
tial sensitivity suggested a speciﬁc survival function of NT3 and
BDNF for type I and II SGNs, respectively. Although subsequent
studies have shown that the speciﬁcity of neurotrophin-dependent
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survival for the two types of SGNs may also depend on the
baso-apical location within the cochlea (Fritzsch et al., 1997;
Farinas et al., 2001), the analysis of a speciﬁc TrkB mutant,
which lacks part of the TrkB intracellular signaling pathway and
survives until adulthood, conﬁrmed this essential role of the
BDNF-TrkB signaling in controlling the survival of type II SGNs
(Schimmang et al., 2003). This targeted survival promoting action
of BDNF was also observed in vitro where treatment of postnatal
SG explants with BDNF rescued essentially the type II population
in the absence of organ of Corti-derived endogenous survival-
promoting factors (Barclay et al., 2011). However, TrkB and TrkC
are expressed in all SGNs, regardless of their type, and both spe-
ciﬁc ligands are located within the hair cells during development
(Farinas et al., 2001), which is not consistent with a differen-
tial localization of neurotrophin support but rather suggests that
the two types of SGNs are endowed with distinct molecular
signaling machineries that are responsible for the preferential sur-
vival promoting action of NT3 and BDNF on the type I and II
SGNs.
Nuclear factor-κB (NFκB) is an inducible transcription fac-
tor that acts as a dimer whose prototype is p50/p65, with p65
containing the transactivation domain. p50/p65 is abundant in
numerous cell types, including neurons, in which it is involved
in a wide range of functions including differentiation and sur-
vival (Meffert and Baltimore, 2005). In its silent state, p50/p65
is sequestered in the cytoplasm by the inhibitory proteins IκBs
(mostly IκBα). Upon activation of an IκB kinase complex, IκBα is
phosphorylated and releases p50/p65 dimers that rapidly translo-
cate into the nucleus and act on gene expression (Hayden and
Ghosh, 2012). In the nervous system, NFκB is widely expressed
and is activated by a variety of neurotrophic factors, including
neurotrophins (Gutierrez and Davies, 2011). In addition, activa-
tion of NFκB prevents neuronal apoptosis in various cell culture
and in vivo models (Mattson et al., 2000). In the present study,
we studied the dynamic expression of NFκB in the developing
rat SGNs. We observed that p65 is ﬁrst expressed in all SGNs
before birth. During postnatal development, p65 is exclusively
present within type II SGNs, an expression proﬁle that remains
unchanged afterwards. Interestingly, during this early postnatal
period, we found a marked p65 activity in type II neurons. At
the same time, we observed that the survival-promoting func-
tion of BDNF, but not of NT3, on cultured SGNs depends on
NFκB activity. Finally, the analysis of p65 knockout mice revealed
a large decrease in the number of type II SGNs. Altogether, our
results propose the p65 subunit of the transcription factor NFκB
as a type II neuron-speciﬁc key molecular factor which distin-
guishes between BDNF- and NT3-dependent survival signaling in
SGNs.
MATERIALS AND METHODS
MOUSE LINES
To examine the role of p65 in SGNs, viable p65−/− mice were
generated on a Tnfr1-deﬁcient background as described previ-
ously (Meffert et al., 2003) and maintained as heterozygous. Mice
were group-housed in the animal facility of the University of Liege
under standard conditions with food and water ad libitum and
were maintained on a 12-h light/dark cycle. All animals were taken
care of in accordance with the declaration of Helsinki and fol-
lowing the guidelines of the Belgian ministry of agriculture in
agreement with EC laboratory animal care and use regulation.
PRIMARY CULTURES OF SGNs
Experiments were performed on Wistar rat SGNs from embry-
onic day (E) 18 to postnatal day (P) 8 rats. Rat species was chosen
here as their cochlea is not or incompletely ossiﬁed at the ages
analyzed, and SG from rat cochlea can be easily isolated. Rats
were euthanized and decapitated. Mandibles were removed, bul-
lae exposed and temporal bones excised and transferred into Petri
dishes containing phosphate buffered saline (PBS) supplemented
with glucose (6 g/l). With the aid of a dissecting microscope
and watchmaker’s forceps, the cochlea was isolated and its SG
excised. SG were incubated for 40 min at 37◦C in a papain-
DNAse solution (1.5 ml of papain at 1 mg/ml, 0.5 ml of DNAse at
0.1%; 20 SG/2 ml solution). Enzymatic activity was terminated by
adding ovalbumin (0.5 ml of a 10 mg/ml solution). The explants
were then washed with DMEM supplemented with N1 additives
(Bottenstein and Sato, 1979) and glucose (6 g/l, ﬁnal concen-
tration). Mechanical dissociation of the SG tissue was achieved
by trituration with a siliconised Pasteur pipette. For cell sur-
vival experiments, the resulting ganglion cell suspension was
seeded in 96-well plates (Nunc, Rockside, Denmark) previously
sequentially coated with poly-L-ornithine (0.1 ng/ml in 15 mM
borate buffer) for 1 h and laminin (10 μg/ml in PBS) for 2 h
at 37◦C. Cells were maintained at 37◦C in a humidiﬁed atmo-
sphere of 5% CO2/95% air. Neurotrophins were purchased from
Peprotech (Rocky Hill, NJ, USA), sulfasalazine, from Sigma (St
Louis, MO, USA) and SN-50, from Calbiochem (San Diego, CA,
USA).
IMMUNOSTAININGS
For immunohistochemistry, rat cochleae were ﬁxed in 4%
paraformaldehyde at 4◦C overnight, decalciﬁed (from P5 onward)
in EDTA solution and transferred into a solution of 30% sucrose
in PBS for an additional overnight incubation at 4◦C. Cochleae
were then embedded in Tissue Tek (Sakura, the Netherlands)
and frozen at −80◦C. Frozen 10–20 μm sections were pre-
pared using a 2800 Frigocut cryostat (Reichert-Jung, Cambridge
Instruments, Germany). Neuronal cultures or cryostat sections
were ﬁxed with 4% paraformaldehyde (10 min at 20◦C). The
preparations were then incubated overnight at 4◦C with pri-
mary antibodies, i.e., anti-betaIII-tubulin (1/1500; clone TUJ1,
Babco, USA), a speciﬁc marker for neuronal lineage (Fanarraga
et al., 1999), and anti-p50 (1/50, Delta Biolabs), anti-p65 and
anti-IκBα (1/50, Santa Cruz Inc., CA, USA). Three washes in
PBS were performed before incubation for 1 h at room temper-
ature, with a secondary antibody conjugated to either peroxidase
(Dako, Glostrup, Denmark), FITC (ﬂuorescein isothiocyanate)
or TRITC (tetramethylrhodamine B isothiocyanate) (Jackson
Immunoresearch Laboratories Inc., West Grove, PA, USA) ﬂu-
orophores. After three rinses in PBS, the immunoﬂuorescent
preparations were mounted on microscope slides, mounted in
Vectashield (Vector, Burlingame, CA, USA) and imaged using an
Olympus FV1000 laser scanning confocalmicroscope. Peroxidase-
labeled cells were revealed using the DAKO Liquid DAB+ kit,
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a high sensitivity substrate-chromogen system (DAKO Diagnos-
tics N.V./S.A., Heverlee, Belgium), and then examined with an
inverted microscope (Zeiss, Axiovert 100, Germany). Negative
controls were carried out by omission of the primary antibody
or by using the blocking peptide for each antibody (data not
shown).
NEURONAL SURVIVAL AND NEURITOGENESIS DETERMINATION
At the end of the culture period, cells were ﬁxed and immunos-
tained for TUJ1 and peroxidase secondary antibody as described
above. Criteria used to determine neuronal viability were (1) TUJ1
positivity, with a large labeled cytoplasm, and (2) an absence
of nuclear pyknosis. The measure of the extent of neurito-
genesis was achieved as previously described (Lallemend et al.,
2005a). Brieﬂy, the number of neurons bearing neuritic pro-
cesses that were of a deﬁned length of at least three neuronal
cell body diameters were counted. Neurites were counted only
if they had an obvious attachment to the neuronal soma. The
neuritic index was calculated as the ratio of neurons bearing
neurites of the deﬁned length or greater per total number of
neurons.
WESTERN BLOT ANALYSIS
A total of about 20 SG (representing one sample) from rat embryos
or pups (E18-P10) were lysed on ice using 100 μl of lysis buffer
(1% triton X-100, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 2 mM
DTT, 1 mM sodium orthovanadate and protease inhibitors cock-
tail; Roche). After 30 min, the lysate was cleared of insoluble debris
by centrifugation for 10 min at 11,000 g. The supernatant was
collected, and the protein concentration was determined using
the Bradford method. Protein lysates (30 μg of proteins) were
then mixed with an equal volume of gel loading buffer (glyc-
erol 20%, SDS 4%, Tris 100 mM, β-mercaptoethanol 5% and
bromophenol blue) before being boiled for 3 min. After boil-
ing, proteins were loaded onto a 10% SDS-PAGE. The proteins
were then transferred on a polyvinylidene diﬂuoride membrane
(Amersham, Roosendaal, the Netherlands) by semi-dry elec-
troblotting in transfer buffer (Glycine 192 mM, Tris 25 mM and
methanol 20%). Blots were then blocked for 1 h at room tem-
perature in blocking buffer [0.2% I-BLOCK (TROPIX, Bedford,
MA, USA) diluted in TBS supplemented with 0.05% Tween 20
(Bio-Rad, Nazareth, Belgium), TTBS]. The primary antibodies
were incubated for 1 h at room temperature in the blocking
buffer. Peroxidase-conjugated monoclonal anti-rabbit antibod-
ies (clone RG-16, Sigma Aldrich, 1:3000) were incubated 1 h
at room temperature. Blots were then washed extensively and
developed by using enhanced chemoluminescence (Pierce, Aalst,
Belgium).
RIBOPROBE SYNTHESIS
pRc/CMV plasmids containing anti-sense and sense primers for
ampliﬁcation of p65 and p50 were kindly provided by Dr. S.
Memet from Pasteur Institute in Paris. Plasmids were cloned in
bacteria mach1TM-T1R (Invitrogen) and isolated using QIAprep
spin miniprep Kit from Qiagen (Germany). The complementary
strands for sense and for antisense riboprobes were transcribed
from either Sp6 or T7 RNA polymerases and labeled using rNTP
mix containing digoxigenin-labeled rNTPpurshached fromRoche
Diagnostics (Germany).
IN SITU HYBRIDIZATION
Riboprobes were diluted to appropriate concentrations in the
hybridization buffer (Amresco) containing 50% formamide and
were denatured for 10 min at 65◦C. Riboprobes were applied to
sections for overnight hybridization in a 50% formamide chamber
at 55◦C. Sectionswerewashed twice in 0.1× SSC (300mMsodium
chloride and 30 mM sodium citrate, pH 7.0) at 55◦C for 30 min.
After a brief wash inTris buffer (0.1MTris-HCl and0.15Msodium
chloride, pH 7.5), sections were blocked in Tris buffer containing
0.5% blocking reagent (catalog #1096176; Boehringer Mannheim)
and 0.3% Triton X-100 and incubated with anti-digoxigenin
antibody conjugated to alkaline phosphatase (1:750; Boehringer
Mannheim). Sections were exposed to staining solution contain-
ing nitroblue tetrazolium salt and 5-bromo-4-chloro-3-indolyl
phosphate for up to 20 h and viewed using an Olympus AX70
microscope.
ELECTROMOBILITY SHIFT ASSAY
Nuclear protein extracts were obtained and processed for elec-
trophoretic mobility shift assay as described previously (Robe
et al., 2004).
STATISTICAL ANALYSIS
Statistical analyses were performed by one-way ANOVA using
a GraphPad Prism program (GraphPad, San Diego, CA, USA).
Individual comparisons were performed using Dunnett’s post hoc
tests. Data were expressed as the mean ± S.D. and results were
considered statistically signiﬁcant if P < 0.05 for both the one-way
ANOVA and the Dunnett’s test.
RESULTS
DEVELOPMENTAL DYNAMIC OF p65, p50 AND IκBα EXPRESSION IN THE
SG
To study the expression of the NFκB complex in the SG, we ﬁrst
analyzed the expression of p65 and p50 transcripts by in situ
hybridization. Data revealed that at P5 (similar results from E18
to 1 year old, data not shown), mRNA for both p50 and p65 are
restricted to the neuronal population (Figures 1A,B). We then
analyzed the general expression pattern of p65, p50 and of IκBα
in whole protein extracts of SG from E18, E19, P1 and P5 animals.
As illustrated in Figure 1C, a semi-quantitative analysis (data are
normalized to the values obtained at E18) showed that the level
of expression of the three proteins remained unchanged during
late embryonic development. However, while the expression of
p50 and IκBα was stable from late embryonic to postnatal stages,
the expression of p65 protein dramatically decreased at P1 and
remained at low level during the following days (Figure 1C).
p65 IS SELECTIVELY EXPRESSED IN TYPE II NEURONS IN POSTNATAL
AND ADULT COCHLEA
The marked decrease of p65 expression in whole SG observed dur-
ing the ﬁrst postnatal week may indicate a general downregulation
of p65 or a selective expression within a speciﬁc neuronal popula-
tion. To address this issue, we examined the temporal and spatial
distribution of p65 expression on cochlear sections of different
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FIGURE 1 | Developmental expression of p65, p50 and IκBα in rat SG.
(A,B) p65 and p50 mRNA expression in P5 rat SG sections assessed by in
situ hybridization. Scale bar: 50 μm. (C) SG proteins were extracted from
E19 to P9 rat cochlea or P5 cerebellum and analyzed by western-blot for the
expression of the p65, p50, IκBα and actin proteins using speciﬁc
antibodies. Densitometric analyzes were performed and results were
expressed as the ratio of targeted proteins versus actin (P9 data are not
shown and are similar to P5). Results are expressed as a percentage of the
ratio quantiﬁed at E19. Note the large decrease in p65 expression
postnatally (**P < 0.01, compare E19 to P3 or P5). The graph represents
the mean of 3–6 experiments.
developmental stages using antibodies against p65, βIII-tubulin (a
general neuronal marker; Fanarraga et al., 1999) and peripherin,
a type III intermediate ﬁlament protein that serves as a reliable
marker for type II neurons at postnatal and adult stages (Haﬁdi,
1998; Lallemend et al., 2007). At late embryonic stage, we observed
that p65 is widely expressed in the whole SG, staining most if
not all sensory neurons (Figures 2A–C). In contrast, after birth,
p65 immunostaining could be visualized in only a few neurons
(Figures 2E–G). This pattern of expression was maintained at
adult stage, where the small size of the p65 immunopositive neu-
rons indicates that they are type II neurons (Figures 2I–K). A
close analysis of the immunostaining at the level of the organ of
Corti revealed a clear staining below the OHCs, but only during
the early postnatal period (Figures 2D,H,L). A further analysis
of both peripherin and p65 expression conﬁrmed that these p65
positive neurons were type II neurons (Figure 3A). OHCs inner-
vation consists of type II afferents from the SG and efferents that
convey information from the brain to the cochlea (Knipper et al.,
1996; Wiechers et al., 1999). To distinguish between these two
types of ﬁbers and conﬁrm that the p65 positive projections below
the OHCs are only type II afferents, we labeled postnatal cochlea
sections for both p65 and synaptophysin, a speciﬁc maker for
presynaptic terminations that stain efferents below the hair cells
(Knipper et al., 1995). Synaptophysin positive nerve endings were
seen below each OHC, but never colocalized with the p65 positive
projections, indicating that these last projections are exclusively
type II afferents (Figure 3B). Later during development, around
P11 when hearing starts in rat, the expression of p65 could no
longer be seen within the SG (data not shown). It reappeared
however, at around P15-16 in type II neuronal cell bodies, but not
in their projections, an expression proﬁle that was maintained at
adult stage (Figure 2L).
In contrast to p65, the expression of p50 was expressed in
all SGNs, but not in their projections, at all stages analyzed
(Figures 2M–X).
TRANSITORY IN VIVO ACTIVITY OF NFκB DURING EARLY POSTNATAL
PERIOD
The above results suggest the participation of NFκB in biolog-
ical processes that regulate the early postnatal development of
type II neurons. To assess whether NFκB particularly is activated
during that period, we studied the DNA-binding activity of p65
in SG at different stages. Using a gel shift assay, we observed
that the activity of p65 subunit in SG nuclear extracts was vir-
tually absent at late embryonic stage, appeared at P1 (data not
shown) and markedly increased at P5 (Figure 4A; NFκB activ-
ity, E19: 1 ± 0.13, P5: 7.27 ± 1.61; n = 4, P < 0.001, t-test,
normalized to E19). These results were conﬁrmed by analyzing
the subcellular localization of p65 in type II neurons at postnatal
stages. Indeed, one hallmark of NFκB activity is its translo-
cation within the nucleus, which could be observed in many
type II neurons at P4-5, as illustrated in Figure 4B. Immuno-
labeling for p65 was never observed in type I neurons after
birth.
BDNF-INDUCED SURVIVAL OF SGNs REQUIRES NFκB SIGNALING
DURING EARLY POSTNATAL PERIOD
The postnatal period is characterized by a reﬁnement of the inner-
vation of the organ of Corti by SGNs, and a concomitant loss
of neurons within the type II population, which depends on
BDNF for their survival (Barclay et al., 2011). To investigate the
implication of NFκB in the signaling of the trophic support medi-
ated by neurotrophins on SGNs during this critical period of
development, SGNs from different stages of development, from
embryonic (E18 and E19) or postnatal (P1, P2, P4, P6, and
P8) animals, were cultured for 24 h in the presence of BDNF
or NT3 together with speciﬁc inhibitors of the NFκB pathway,
i.e., SN50 that blocks nuclear translocation of NFκB (Lin et al.,
1995) and sulfasalazine (SZ) that interferes with the phosphoryla-
tion of IκBα (Wahl et al., 1998). Both neurotrophins were shown
to signiﬁcantly increase survival of SGNs (P < 0.01 at P8 and
P < 0.001 at E18-P6, compared to control) from embryonic or
postnatal animals, as previously shown (Malgrange et al., 1996;
Mou et al., 1997, 1998). Strikingly, while inhibitors of NFκB did
not affect the survival-promoting activity of NT3 at all stages ana-
lyzed (P > 0.05, Figures 5A,C), the trophic action of BDNF was
speciﬁcally and only affected during the early postnatal period
of development, from P1 to P6, with a maximum of inhibition
observed at P4 (Figures 5B,C; P > 0.05, BDNF+SN50 compared
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FIGURE 2 | Distribution of p65 and p50 proteins in the developing
cochea. (A–L) Representative confocal images for the expression of p65
subunit (green) and the neuronal marker TUJ1 (red) on rat SG (A–C, E–G, I–K;
scale bar: 100 μm) and corresponding organs of Corti (OC; D,H,L; scale bar:
40 μm) from E19, P5 and P35 rat cochlear sections. Inset inA (A’), represents
immunoblotting for p65 from P5 rat SG total protein extract which reveals a
speciﬁc single band staining at the expected molecular weight. (M–X)
Representative confocal images for the expression of p50 subunit (green) and
the neuronal marker TUJ1 (red) on rat SG (M–O, Q–R, U–W; scale bar:
100 μm) and OC (P,T,X; scale bar: 40 μm) from E19, P5 and P35 rat cochlear
sections. Inset in M (M’), represents immunoblotting for p50 from P5 rat SG
total protein extract which reveals a speciﬁc single band staining at the
expected molecular weight. On the same immunoblot, the speciﬁc band
corresponding to p105 is not shown.
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FIGURE 3 | Preferential expression of p65 in postnatal type II SGNs. (A)
Double immunostaining for p65 and peripherin on SG sections from P7 rats
showing restriction of p65 expression in peripherin+ type II neurons (arrows).
(B) Double immunostaining for synaptophysin (efferent marker) and for p65 on
P7 rat cochlear section at the level of the organ of Corti showing the absence
of colocalization (arrow and inset). 1–3: the three rows of outer hair cells;
asterisk: the inner hair cell; thin arrow: the position of the higher magniﬁcation
represented in the inset; thick arrow: efferent nerve endings under IHC.
to control). In addition to their survival action, neurotrophins
have been shown to affect axonal growth both in vivo and in
vitro (Defourny et al., 2011). Interestingly, inhibitors of NFκB did
not change the BDNF-induced axon growth of SGNs from P4
animals (P > 0.05), suggesting a speciﬁc requirement of NFκB
signaling for survival but not general axon growth promoted by
BDNF.
LOSS OF PERIPHERIN+ SGNs IN THE ABSENCE OF p65 IN VIVO
To examine the requirement for p65 during development of type
II neurons in vivo, we changed the model system and analyzed
null mutant mice for p65. Since p65−/− mice die at E14–15 from
massive liver apoptosis mediated through TNFR1 signaling (Beg
et al., 1995; Rosenfeld et al., 2000), we generated mice that were
deﬁcient in both p65 and Tnfr1 and analyzed neuronal phenotype
in cochlea of young adult animals (P21). Interestingly, although
the total number of SGNs (i.e., βIII-tubulin+ cells per section)
showedno signiﬁcant difference betweenTnfr1−/− andTnfr1−/−;
p65−/− mice (Tnfr1−/−; p65+/+: 92.3± 14.4;Tnfr1−/−; p65−/−:
74 ± 4.8, n = 3, P > 0.1), the number of peripherin+ type II
neurons (which only represents around 10% of the whole neu-
ronal population) was dramatically reduced in the absence of p65
(Figures 6A–C), whereas experiments with wild-typemice yielded
similar numbers as seen for Tnfr1−/−; p65+/+ (data not shown).
Together with our in vitro analysis, these data show that BDNF
through NFκB signaling is required to support a signiﬁcant frac-
tion of the type II neuronal population during early postnatal
development of the cochlea.
We next sought to deﬁne the dynamic of BDNF expression dur-
ing this critical postnatal period of development. At P0, BDNF was
found to be expressed in the sensory epithelium and nerve endings
below the hair cells while the cell bodies of the neurons were not
or barely positive (Figures 6D,E). In contrast, at P3, while BDNF
was expressed in the cell bodies of most neurons (Figure 6G),
regardless of the type (in both peripherin positive and negative
SGNs, data not shown), it was absent in hair cells (Figure 6F),
conﬁrming previous results (Wiechers et al., 1999) and suggesting
a local (autocrine and/or paracrine) function of BDNF in sustain-
ing survival of type II population during the postnatal period of
development.
FIGURE 4 | Postnatal activation of p65 in type II SGNs. (A) Nuclear
extracts from E19 and P5 SG were analyzed by EMSA using a speciﬁc κB
probe. Note the large increase in DNA-protein complex observed
postnatally. (B) Double immunostaining for peripherin (green) and for p65
(red) on P5 rat SG section showing nuclear staining for p65 in a type II
neuron. Scale bar: 10 μm.
DISCUSSION
Although the assignment of NT3 for the survival of type I SGNs
during development is still unclear, the trophic function of BDNF
on type II neurons has been largely documented, both in vitro
and in vivo (Ernfors et al., 1995; Wiechers et al., 1999; Schimmang
et al., 2003; Barclay et al., 2011). However, BDNF is expressed in
both IHCs and OHCs during early development and its high afﬁn-
ity receptor TrkB, in all SGNs, raising the question to know what
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FIGURE 5 | NFκB is necessary for BDNF but not NT3-induced survival
of postnatal SGNs. (A–C) SGNs were cultured for 24 h with BDNF or
NT3 (each at 20 ng/ml) and in the presence of speciﬁc inhibitors of the
NFκB signaling, SN50 (5 μM) (A,B) or sulfasalazine (1 mM, sz; P4, C).
Note the absence of effect of the inhibitors on survival function of NT3
while they dramatically decrease the survival promoting action of BDNF
(n = 3–8; *P < 0.05, **P < 0.01, ***P < 0.001; compared to
neurotrophin alone).
mechanisms may mediate the differential responsiveness of type
I and II neurons to NT3 and BDNF. Here, we show that p65 is
selectively expressed in type II neurons postnatally and that NFκB
activity is required speciﬁcally for BDNF- but not NT3-dependent
survival of postnatal SGNs in vitro. Consistently, p65−/− mice dis-
play large deﬁcits in the survival of type II SGNs in vivo. Thus, p65
represents the ﬁrst identiﬁed transcription factor that selectively
regulates the survival of type II SGNs during development.
SGNs develop from the neurogenic compartment of the otic
vesicle during mid-embryonic stage in rodents (Appler and
Goodrich, 2011). During the following days, they send axonal
projections to hair cells in the organ of Corti and the central
nervous system and progressively differentiate into type I and
II neurons, which clearly distinguish perinatally (Koundakjian
et al., 2007). Apart from their characteristic peripheral connec-
tions with OHCs, type II neurons can be recognized postnatally
by their speciﬁc expression of peripherin (Lallemend et al., 2007).
We show here that the expression of p65 is present in virtu-
ally all neurons until birth and selectively expressed at high
level in the type II population thereafter. Such speciﬁcity for
type II neurons is unlikely to be limited to rat species, as sim-
ilar pattern of p65 expression has been previously reported in
gerbils (Lang et al., 2005). Moreover, the characteristic loss of
type II neurons in mice lacking p65 strongly supports the speci-
ﬁcity of p65 expression for type II neurons after birth also in
mice.
The tight control of p65 postnatally coincides exactly with
peripherin down regulation and the onset of myelin marker
expression in type I neurons (Knipper et al., 1998; Lallemend
et al., 2007), indicating that a speciﬁc transcriptional machin-
ery implicating both repressor and activator functions operates
simultaneously at this stage to clearly deﬁne the two neuronal
phenotypes of the cochlea. Interestingly, the observation that
the transcript for p65 but not the protein is found in type I
neurons after birth suggests the existence of post-translational
mechanisms (e.g., neuron type-speciﬁc miRNA expression) that
would ensure speciﬁc expression of p65 protein in type II neu-
rons. Also, the fact that p65 is active only during the postnatal
period while its expression is observed before birth in both neu-
ron types implies a tight regulation of signaling pathways that
would control the activation of NFκB. This could be done at the
cellular levels for instance by regulating either the expression of
IκB kinases, which phosphorylate and inhibit IκBs (Hayden and
Ghosh, 2012), or the relative amount of p65 and p50 in the neuron,
what would impact the formation of potentially transcription-
ally active p65/p50 heterodimers versus p50 homodimers that are
transcriptionally inactive or negative regulators of transcription
(Hayden and Ghosh, 2012).
The early outgrowth of peripheral projections of SGNs leads
at birth to an incomplete innervation pattern in the organ of
Corti, where IHCs and OHCs have been shown to be innervated
by both types of neurons (Huang et al., 2007). This immature
conﬁguration is corrected during the following days by a pro-
gressive pruning ultimately providing the adult-like innervation
pattern where type I and II neurons contact exclusively the IHCs
and OHCs, respectively (Huang et al., 2007; Defourny et al., 2011).
This reorganization is accompanied by a 25% neuronal loss that
mostly concerns the type II population (Rueda et al., 1987; Bar-
clay et al., 2011) and likely participates in the elimination of type
II afferents underneath the IHCs. Interestingly, early postnatal
type II neurons are rescued by BDNF in vitro (Barclay et al.,
2011). NFκB signaling has been shown to act downstream of neu-
rotrophic factor receptors (including Trks) activation to promote
neuronal survival (Maggirwar et al., 1998; Huang and Reichardt,
2003; Mincheva et al., 2011). The observation in our study of a
speciﬁc requirement of p65 signaling for BDNF-induced survival
of early postnatal SGNs in vitro and of its speciﬁc role in reg-
ulating survival of type II neurons in vivo strongly suggest that
NFκB represents a key molecular component driving the differen-
tial survival promoting action of BDNF on type II neurons. The
maintenance of p65 expression in type II SGNs in adult raises
the question whether NFκB would play a similar survival function
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FIGURE 6 | Loss of type II SGNs in p65-deficient mice. (A,B)
Immunostaining for peripherin on SG sections fromTnfr1−/− (A) andTnfr1−/−;
p65−/− mice (B), showing dramatic loss of type II population in the absence
of p65. (C) Quantiﬁcation of (A,B) (n = 3; **P < 0.01). (D–G) Immunostaining
for βIII-tubulin, BDNF and peripherin on sections of organ of Corti (D,F) or SG
(E,G) from P0 (D,E) and P3 (F,G) mouse cochlea. Note expression of BDNF in
the OHC (1 to 3) and IHC (asterisk) at P0 (D) but not at P3 (F). Also, while
BDNF expression is observed in afferent endings of IHC and OHC at both P0
(D) and P3 (F), it is hardly seen in the soma of SGNs at P0 (E, arrow points to
a positive afferent), but upregulated there at P3.
on this population under stress conditions, where neuroinﬂam-
matory factors and calcium signaling, both known to be able to
activate NFκB (Meffert et al., 2003; Hayden and Ghosh, 2012),
play an important role (Gale et al., 2004; Lallemend et al., 2005b;
Tornabene et al., 2006; Keithley et al., 2008).
The spatio-temporal dynamic expression of p65 in SGNs
observed in our study is accompanied by changes in the expres-
sion proﬁle of BDNF in the cochlear system. Indeed, we and others
have shown that BDNF is downregulated in the sensory epithelium
and start to be expressed in the majority of neurons (type I and
II) during the ﬁrst postnatal week (Wheeler et al., 1994; Wiech-
ers et al., 1999; present study). This downregulation of BDNF in
the organ of Corti might contribute to afferent ﬁber retraction
from the hair cells (Wheeler et al., 1994). The initiation of BDNF
expression in SGNs at the same stage could then provide a tran-
sient autocrine and/or paracrine signal whereby type II neurons,
deprived of organ of Corti-derived trophic signals, could survive
until BDNF is again supplied by their target at later stage (Wiechers
et al., 1999).
Another interesting aspect of our data is that the intracellular
signalingpathwayof BDNFandNT3 is clearly different and impor-
tant for their survival promoting effect. Because SGNs express
both TrkB and TrkC receptors (Mou et al., 1997; Farinas et al.,
2001), these differences are likely operating within the same neu-
rons. Indeed, we show here that BDNF but not NT3 uses NFκB
signaling for promoting survival of postnatal SGNs. As a result,
postnatal type II neurons, which upregulate p65, will be more
likely to be rescued by BDNF compared to type I neurons (Barclay
et al., 2011), which is consistent with our in vivo results showing a
selective loss of type II neurons in the absence of p65. Moreover,
our results also suggest at least in vitro that BDNF would utilize
different signaling pathways to promote either survival, through
NFκB, or general axonal growth independently of NFκB. Similar
dissociation of intracellular effectors leading to distinct biological
functions has been previously described in vivo (Postigo et al.,
2002). Although interesting, this observation will require further
analysis of the possible function of NFκB on the ﬁne arborization
at nerve endings, as seen for pyramidal neurons in vitro (Gutierrez
et al., 2005).
Altogether, these results underline the importance of under-
standing the differences in the neuron-type speciﬁc molecular
machinery which are responsible for mediating distinct biological
responses to neurotrophins and that ultimately control the proper
development of the peripheral nervous system.
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